396 related articles for article (PubMed ID: 33160969)
1. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.
Sharif H; Acharya S; Dhondalay GKR; Varricchi G; Krasner-Macleod S; Laisuan W; Switzer A; Lenormand M; Kashe E; Parkin RV; Yi Y; Koc M; Fedina O; Vilà-Nadal G; Marone G; Eifan A; Scadding GW; Fear DJ; Nadeau KC; Durham SR; Shamji MH
J Allergy Clin Immunol; 2021 Feb; 147(2):663-676. PubMed ID: 33160969
[TBL] [Abstract][Full Text] [Related]
2. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
[TBL] [Abstract][Full Text] [Related]
3. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.
Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR
Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605
[TBL] [Abstract][Full Text] [Related]
4. Nasal allergen-neutralizing IgG
Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-35 in sublingual allergen immunotherapy.
Shamji MH; Layhadi JA; Achkova D; Kouser L; Perera-Webb A; Couto-Francisco NC; Parkin RV; Matsuoka T; Scadding G; Ashton-Rickardt PG; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1131-1142.e4. PubMed ID: 30053528
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.
Shamji MH; Larson D; Eifan A; Scadding GW; Qin T; Lawson K; Sever ML; Macfarlane E; Layhadi JA; Würtzen PA; Parkin RV; Sanda S; Harris KM; Nepom GT; Togias A; Durham SR
J Allergy Clin Immunol; 2021 Oct; 148(4):1061-1071.e11. PubMed ID: 33819508
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
[TBL] [Abstract][Full Text] [Related]
8. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
[TBL] [Abstract][Full Text] [Related]
9. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
[TBL] [Abstract][Full Text] [Related]
10. Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy.
Schulten V; Tripple V; Aasbjerg K; Backer V; Lund G; Würtzen PA; Sette A; Peters B
Clin Exp Allergy; 2016 Mar; 46(3):439-48. PubMed ID: 26436865
[TBL] [Abstract][Full Text] [Related]
11. Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge.
Scadding GW; Eifan AO; Lao-Araya M; Penagos M; Poon SY; Steveling E; Yan R; Switzer A; Phippard D; Togias A; Shamji MH; Durham SR
Allergy; 2015 Jun; 70(6):689-96. PubMed ID: 25773990
[TBL] [Abstract][Full Text] [Related]
12. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
13. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
15. Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.
Rondón C; Blanca-López N; Campo P; Mayorga C; Jurado-Escobar R; Torres MJ; Canto G; Blanca M
Allergy; 2018 Apr; 73(4):905-915. PubMed ID: 29168570
[TBL] [Abstract][Full Text] [Related]
16. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.
Lawrence MG; Steinke JW; Borish L
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):138-42. PubMed ID: 27499541
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
18. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
Manzotti G; Riario-Sforza GG; Dimatteo M; Scolari C; Makri E; Incorvaia C
Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):224-227. PubMed ID: 27852426
[TBL] [Abstract][Full Text] [Related]
19. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]